Discovery of Precision Oncology Drugs
NTRC provides in vitro drug discovery services focused on Precision Medicine. We help you to find the informed route to the clinic. Information can be found at www.oncolines.com
Predictive Precision Medicine Platform for Ovarian Cancer
The poster presents a biomarker discovery platform using ascites of ovarian cancer patients. The aim is to develop a Precision Medicine Platform to predict the clinical response to chemo- and immunotherapy for epithelial ovarian cancer patients.